References

Management of toxicities associated with novel immunotherapy agents in acute lymphoblastic leukemia

10.1177/2040620719899897 · 2020 · External reference

Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems

10.1038/s41573-023-00670-0 · 2023 · External reference

Improving treatment adherence in patients with rheumatoid arthritis: what are the options?

10.2217/ijr.15.39 · 2015 · External reference

Antibody-based protection against HIV infection by vectored immunoprophylaxis

10.1038/nature10660 · 2011 · External reference

In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections

10.1016/j.omtm.2017.09.003 · 2017 · External reference

Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys

10.1038/nm.1967 · 2009 · External reference

Lentiviral gene therapy with CD34+ hematopoietic cells for hemophilia A

10.1056/nejmoa2410597 · 2025 · External reference

Reprogramming the antigen specificity of B cells using genome-editing technologies

10.7554/elife.42995 · 2019 · External reference

Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion

10.1038/s41467-020-19649-1 · 2020 · External reference

HIV-specific humoral immune responses by CRISPR/Cas9-edited B cells

10.1084/jem.20190287 · 2019 · External reference

Vaccine Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells

10.1038/s41467-020-19650-8 · 2020 · External reference

B cells engineered to express pathogen-specific antibodies protect against infection

10.1126/sciimmunol.aax0644 · 2019 · External reference

Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration

10.1038/s41419-020-03187-1 · 2020 · External reference

Lifetime of plasma cells in the bone marrow

10.1038/40540 · 1997 · External reference

Duration of humoral immunity to common viral and vaccine antigens

10.1056/nejmoa066092 · 2007 · External reference

Single-cell deep phenotyping of IgG-secreting cells for high-resolution immune monitoring

10.1038/nbt.3964 · 2017 · External reference

Competence and competition: the challenge of becoming a long-lived plasma cell

10.1038/nri1886 · 2006 · External reference

Limiting dilution analysis of the B cell compartment in human bone marrow

10.1002/eji.1830160206 · 1986 · External reference

Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo

10.1038/s41467-022-33787-8 · 2022 · External reference

Human plasma cells engineered to secrete bispecifics drive effective in vivo leukemia killing

10.1016/j.ymthe.2024.06.004 · 2024 · External reference

B cells as drug factories

10.1038/s41587-024-02283-3 · 2024 · External reference

Engineering Protein-Secreting Plasma Cells by Homology-Directed Repair in Primary Human B Cells

10.1016/j.ymthe.2017.11.012 · 2018 · External reference

Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-Balb/c-Rag1-/-gammac-/-and C.B-17-scid/bg immunodeficient mice

10.1016/j.humimm.2009.06.005 · 2009 · External reference

The Bone Marrow as Sanctuary for Plasma Cells and Memory T-Cells: Implications for Adaptive Immunity and Vaccinology

10.3390/cells10061508 · 2021 · External reference

Macrophages induce differentiation of plasma cells through CXCL10/IP-10

10.1084/jem.20112142 · 2012 · External reference

Humoral immunity in humanized mice: a work in progress

10.1093/infdis/jit448 · 2013 · External reference

BAFF selectively enhances the survival of plasmablasts generated from human memory B cells

10.1172/jci18025 · 2003 · External reference

BAFF bestows longevity on splenic plasma cells

10.1182/blood-2018-02-832089 · 2018 · External reference

BCMA is essential for the survival of long-lived bone marrow plasma cells

10.1084/jem.20031330 · 2004 · External reference

IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors

10.1038/leu.2014.61 · 2014 · External reference

IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells

10.4049/jimmunol.175.12.7867 · 2005 · External reference

Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage

10.3389/fimmu.2014.00065 · 2014 · External reference

Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells

10.4049/jimmunol.174.10.6477 · 2005 · External reference

Improved multilineage human hematopoietic reconstitution and function in NSGS mice

10.1371/journal.pone.0209034 · 2018 · External reference

An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus

10.1016/j.immuni.2018.03.026 · 2018 · External reference

The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor

10.1182/blood.v69.5.1307.1307 · 1987 · External reference

BCR signaling is required for posttransplant lymphoproliferative disease in immunodeficient mice receiving human B cells

10.1126/scitranslmed.adh8846 · 2024 · External reference

IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2

2022 · External reference

Functional engraftment of human peripheral T and B cells and sustained production of autoantibodies in NOD/LtSzscid/IL-2Rγ(-/-) mice

10.1002/eji.201444729 · 2014 · External reference

Production of therapeutic levels of human FIX-R338L by engineered B cells using GMP-compatible medium

10.1016/j.omtm.2023.101111 · 2023 · External reference

The establishment of the plasma cell survival niche in the bone marrow

10.1111/imr.12011 · 2013 · External reference

Humoral immunity due to long-lived plasma cells

10.1016/s1074-7613(00)80541-5 · 1998 · External reference

Intrinsically determined turnover underlies broad heterogeneity in plasma-cell lifespan

10.1016/j.immuni.2023.04.015 · 2023 · External reference

Progressive differentiation toward the long-lived plasma cell compartment in the bone marrow

10.1084/jem.20221717 · 2023 · External reference

Monocytes derived from humanized neonatal NOD/SCID/IL2Rγ(null) mice are phenotypically immature and exhibit functional impairments

10.1016/j.humimm.2012.01.006 · 2012 · External reference

Human hemato-lymphoid system mice: current use and future potential for medicine

10.1146/annurev-immunol-032712-095921 · 2013 · External reference

In vivo tracking of ex-vivo-generated 89Zr-oxine-labeled plasma cells by PET in a non-human primate model

10.1016/j.ymthe.2024.12.042 · 2025 · External reference

Cross-species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding

10.1074/jbc.m109.081828 · 2010 · External reference

FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion

10.1136/jitc-2020-000619 · 2020 · External reference

Mouse strains influence clearance and efficacy of antibody and antibody-drug conjugate via Fc-FcγR interaction

10.1158/1535-7163.mct-18-0977 · 2019 · External reference

Crosstalk between human IgG isotypes and murine effector cells

10.4049/jimmunol.1200356 · 2012 · External reference

Antibody-dependent cellular phagocytosis by macrophages is a novel mechanism of action of elotuzumab

10.1158/1535-7163.mct-17-0998 · 2018 · External reference

Enhanced development of functional human NK cells in NOD-scid-IL2rgnull mice expressing human IL15

10.1096/fj.202200045r · 2022 · External reference

Human Hematopoietic Stem Cell Engrafted IL-15 Transgenic NSG Mice Support Robust NK Cell Responses and Sustained HIV-1 Infection

10.3390/v15020365 · 2023 · External reference

NK Cell-Fc Receptors Advance Tumor Immunotherapy

10.3390/jcm8101667 · 2019 · External reference

Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice

10.2337/diab.42.11.1574 · 1993 · External reference

A novel hemolytic complement-sufficient NSG mouse model supports studies of complement-mediated antitumor activity in vivo

10.1016/j.jim.2017.03.021 · 2017 · External reference

Kit regulates HSC engraftment across the human-mouse species barrier

10.1016/j.stem.2014.06.001 · 2014 · External reference

A humanized mouse that mounts mature class-switched, hypermutated and neutralizing antibody responses

10.1038/s41590-024-01880-3 · 2024 · External reference

LysRS serves as a key signaling molecule in the immune response by regulating gene expression

10.1016/j.molcel.2009.05.019 · 2009 · External reference

Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein

10.1083/jcb.104.3.761 · 1987 · External reference

Engineering a therapeutic IgG molecule to address cysteinylation, aggregation and enhance thermal stability and expression

10.4161/mabs.23392 · 2013 · External reference

Aggregation-resistant domain antibodies engineered with charged mutations near the edges of the complementarity-determining regions

10.1093/protein/gzs042 · 2012 · External reference

Antibody production relies on the tRNA inosine wobble modification to meet biased codon demand

10.1126/science.adi1763 · 2024 · External reference

SEC-seq: association of molecular signatures with antibody secretion in thousands of single human plasma cells

10.1038/s41467-023-39367-8 · 2023 · External reference

A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

10.4049/jimmunol.2000583 · 2020 · External reference

Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19

10.1016/j.cell.2020.11.029 · 2021 · External reference

2FAST2Q: a general-purpose sequence search and counting program for FASTQ files

10.7717/peerj.14041 · 2022 · External reference

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays

10.3390/v12050513 · 2020 · External reference